Mark Thomas Esser

Primary Appointment

Chief Scientific Officer and Head of the Paul and Diane Manning Institute of Biotechnology, Microbiology, Immunology, and Cancer Biology

Research Interests

Immunology, vaccines and biologic drugs, virology and microbiology, diagnostics and biomarkers, clinical research and development, business development and navigating federal research regulations and submissions.